/CaM-dependent inactivation (CDI) of LTCCs, whether channels were heterologously expressed in HEK293 cells, or present in native form within myocytes. This attenuation of CDI is predicted to promote action-potential prolongation and boost Ca 2+ influx.
Introduction
Calmodulin (CaM) is a ubiquitous Ca 2+ -sensor molecule that modulates a vast array of proteins, thereby controlling signaling cascades via Ca 2+ -dependent adjustment of relevant proteins. As such, CaM critically orchestrates numerous functions, including cellular excitability, muscle contraction, memory, and immunological responses [1, 2] . So important are the functions of CaM that it has long been thought that naturally occurring mutations within this molecule would prove lethal, and that such mutations would thereby play little role in disease processes afflicting living individuals.
Yet, a role for CaM in a number of diseases has begun to emerge. Alterations in the overall level of CaM have been implicated in heart failure [3] , schizophrenia [4] , and Parkinson's disease [5] [6] [7] . Outright CaM mutations in Drosophila have been associated with muscle malfunction [8] . Very recently, human genetic studies uncovered de novo and heritable CaM mutations (N54I and N98S, start methionine denoted residue 1) that are associated with 11 cases of catecholaminergic polymorphic ventricular tachycardia (CPVT), where altered CaM-ryanodine receptor function is implicated as a major contributing factor [9] . Further, wholeexome sequencing and targeted gene sequencing have revealed an association between three de novo missense CaM mutations and severe long-QT syndrome (LQTS) with recurrent cardiac arrest [10] . The first hints of underlying mechanism can be gleaned by relating the locations of these mutations to the basic structure-function layout of CaM, a 17 kDa protein comprised of N-and C-terminal lobes linked by a flexible helix. Each lobe of CaM contains two EF hands, canonical Ca 2+ binding motifs, with the N-lobe having slightly lower Ca 2+ binding affinity.
Ca 2+ binding to these EF hands induces a conformational change that alters function of target molecules to which CaM is bound, thus transducing changes of intracellular Ca 2+ concentration [11] into modulation of molecular function. Each of the LQTS mutations (D96V, D130G, and F142L, with start methionine denoted residue 1) resides at or near Ca 2+ coordinating residues within the EF hands of the C-lobe of CaM, and have been shown to decrease affinity for Ca 2+ binding [10] . By contrast, the reported CPVT mutations in CaM imparted little-to-mild reduction of Ca 2+ binding affinity [9] . It is perhaps interesting to speculate that the contrasting effects on Ca 2+ binding may underlie the elaboration of distinguishable LQTS and CPVT phenotypes by these two classes of mutations. At present, however, the mechanisms linking these mutations in CaM to their corresponding disease phenotypes are essentially unknown. That said, progress towards elucidating these mechanisms will ultimately prove invaluable in devising personalized therapeutics for afflicted individuals, and in gleaning general lessons about LQTS pathogenesis from these single-point-mutation case examples. Among the most prominent mechanistic unknowns are the following. First, do the LQTS CaM mutations actually cause the emergence of LQTS substrates in heart? At present, no experimental evidence directly establishes causality. Second, what are the predominant molecular targets through which CaM mutations exert their actions in heart? Likely cardiac myocyte targets abound, including ryanodine receptors (RyR2), voltage-gated Na channels (Na V 1.5), slowly activating delayed-rectifier K channels (I Ks ), and L-type Ca 2+ channels [10] [11] [12] (Ca V 1.2). All of these contribute to shaping action-potential morphology and thereby represent plausible candidates. Third, the severity of the LQTS fits in a seemingly incongruous fashion with the redundancy of human CaM genes (CALM1, CALM2, and CALM3), each of which encodes for an identical CaM molecule at the protein level. Given the heterozygosity of these LQTS patients [10] , this redundancy implies that only one of six alleles of CaM would possess a mutation, yielding only a portion of mutant versus wild-type CaM.
Here, therefore, we acutely introduce LQTS CaM mutants into adult guinea-pig ventricular myocytes (aGPVMs) and demonstrate marked prolongation of action potentials, along with intense disturbance of Ca 2+ cycling. As these effects are reminiscent of those we observed previously by man-made CaM mutants acting strongly through diminished CaM-mediated regulation of L-type Ca 2+ channels [13] (LTCCs), we tested directly for the effects of naturally occurring LQTS CaM mutants on these very channels. Indeed, we establish that Ca 2+ regulation of LTCCs can be strongly suppressed by overexpression of LQTS CaM mutants, posturing altered regulation of these channels as an important contributor to the LQTS phenotype. By contrast, overexpressing CPVT CaM mutants caused weaker or undetectable perturbation of LTCC function and action potentials. Finally, we note the requirement that a single Ca
2+
-free CaM (apoCaM) must first preassociate with LTCCs for subsequent Ca 2+ regulation to occur [5, 11, [14] [15] [16] [17] , and substantiate how this feature rationalizes how a limited fraction of LQTS CaM mutants can nonetheless elaborate significant perturbation of channel regulation, sufficient to appreciably prolong action potentials.
Methods

Adult guinea-pig ventricular myocyte isolation and adenoviral transduction
Adult guinea-pig ventricular myocytes (aGPVMs) were isolated from whole hearts of adult guinea pigs (Hartley strain, 3-4 wk old, weight 250-350 g). Hearts were excised after guinea pigs were anesthetized with pentobarbital (35 mg/kg, intraperitoneal injection). Single ventricular myocytes were isolated from both ventricles according to a published protocol [18] and plated on glass coverslips coated with laminin (20 μg/ml overnight at 4°C). Cells were transduced with adenovirus carrying wild-type or mutant CaM upon plating in the presence of M199 medium supplemented with 20% fetal bovine serum. Expression of wild-type CaM had little effect on action-potential morphology or duration, as compared to uninfected myocytes ( Supplementary Fig. 1 ). After 4 h, the medium was replaced by M199 medium with 0% fetal bovine serum to maintain the phenotype of acutely dissociated myocytes. Cells were maintained at 37°C and recording was done at room temperature 20-36 h later.
Molecular biology
LQTS CaM mutations were generated using QuikChange™ sitedirected mutagenesis (Agilent Technologies, Inc.) on rat brain CaM (M17069) in the pcDNA3 vector (Invitrogen). CPVT CaM mutations were generated on human CALM1 gene in the pcDNA3 vector (a kind gift from Michael T. Overgaard [9] ). For electrophysiological recordings in HEK293 cells, both wild-type and LQTS mutant CaMs were cloned into the pIRES2-EGFP vector (Clontech Laboratories, Inc.) using NheI and BglII. For adenoviral expression in aGPVMs, wild-type and mutant CaMs were cloned into the pAdCiG viral shuttle vector using XhoI and SpeI. Adenovirus was amplified via a standard cre-recombinase method as previously described [13] .
The human cardiac α 1C cDNA was constructed by cloning in añ 1.6 kbase upstream fragment of the cardiac (containing exon 8a) channel variant (kind gift from Tuck Wah Soong [19] ) into a human α 1C-1 backbone (NM_000719 kindly gifted from Charlie Cohen of Merck Pharmaceuticals) contained within pcDNA3.1, via HindIII and ClaI sites.
For FRET two-hybrid constructs, CaM and CI region of Ca V 1.2 channels (as defined in Fig. 5A and described previously [14] ) were tagged on their amino termini with fluorophores (cerulean and venus, respectively) with a linker of 3 alanines, and cloned into the pcDNA3.0 (Invitrogen) using KpnI and XbaI.
Transfection of HEK293 cells
For whole-cell patch clamp experiments, HEK293 cells were cultured on glass coverslips in 10-cm dishes and Ca 2+ channels were transiently transfected using a standard calcium phosphate method [20] . 8 μg of human cardiac α 1C cDNA (as described above) was co-expressed heterologously with 8 μg of rat brain β 2a (M80545), 8 μg of rat brain α 2 δ (NM_012919.2) subunits, and 8 μg of wild-type or mutant CaMs, except for mixing experiments (Fig. 6 ) where various molar ratios of wild-type to mutant CaM were transfected. The auxiliary β 2a subunit was chosen so as to minimize the confounding effects of voltage-dependent inactivation on Ca 2+ /CaM-dependent inactivation [21] . To increase expression levels, 2 μg of simian virus 40 T antigen cDNA was co-transfected. Expression of all constructs was driven by a cytomegalovirus promoter.
For FRET two-hybrid experiments, HEK293 cells were cultured on glass-bottom dishes and transfected with polyethylenimine [22] (PEI) before epifluorescence imaging. Whole-cell patch clamp and FRET two-hybrid experiments were performed 1-2 days after transfection.
Electrophysiology
Whole-cell voltage-clamp recordings of HEK293 cells were done 1-2 days after transfection at room temperature. Recordings were obtained using an Axopatch 200B amplifier (Axon Instruments). Whole-cell voltage-clamp records were lowpass filtered at 2 kHz, and then digitally sampled at 10 kHz. P/8 leak subtraction was used, with series resistances of 1-2 MΩ. For voltage-clamp experiments, internal solutions contained (in mM): CsMeSO 3 7.4) . Junction potentials for current-clamp solutions were calculated to be only 0.5 mV [24] . The time from upstroke to 80% repolarization (APD 80 ) was used as the metric for action potential duration throughout. SD cell , the mean standard deviation of APD 80 within individual cells, was used to assess the dispersion of APD 80 at the same expression level of CaM. Throughout, whole-cell voltage-clamp records were lowpass filtered at 2 kHz, and then digitally sampled at 10 kHz. Current-clamp recordings were filtered at 5 kHz, and sampled at 25 kHz.
Ratiometric Ca 2+ imaging
Single aGPVMs were plated on glass-bottom dishes coated with laminin. Cells were loaded with Indo-1 AM (1 μM) at room temperature for 5 min, rinsed, and further incubated for 10 min in Tyrode's solution at room temperature to allow for de-esterification of Indo-1 AM. Cells were stimulated by application of an electric field across individual cells using a Grass stimulator (SDD9) and bipolar point platinum electrodes. Recordings were made at room temperature in Tyrode's solution supplemented with 10 μM ascorbic acid [25] 
. R is the ratio of fluorescence signal at 405 and 485 nm. K d/Indo was determined as 800 nM [26] . R min was determined to be 0. 53 
Results
CaM mutants promote proarrhythmic electrical and Ca 2+ activity in ventricular myocytes
CaM mutations have been associated with severe LQTS and recurrent cardiac arrest [10] , but to date, no direct evidence exists that these mutations can actually promote proarrhythmic properties in an experimental cardiac model. Accordingly, before investigating specific Ca 2+ regulatory disturbances relating to the interaction of LQTS CaM mutants and individual molecular targets, we tested whether the expression of these mutants at all perturbed the overall electrical and Ca 2+ cycling properties of aGPVMs. This particular model was chosen because it features action potentials with a prominent plateau phase reminiscent of that in humans, making this system particularly suitable for understanding long-QT phenomena. Fig. 1A displays the prototypic action potentials of a single such myocyte expressing only wild-type CaM (CaM WT ), obtained at 0.5-Hz stimulation under whole-cell current clamp. The timing of current injection stimuli is shown underneath for orientation. The waveforms are nearly identical from one stimulus to the next, with a mean action potential duration (APD 80 ) of~300 ms [13] . Population behavior for APD 80 is summarized in Fig. 1B , which plots the cumulative distribution of durations drawn from 285 responses in 10 cells, where P APD is the probability that APD 80 is less than the value on the abscissa. The sharp rise of the distribution confirms a mean duration of 349.6 ms, with a modest standard deviation of 79.6 ms. Additionally, the mean standard deviation of APDs within individual myocytes (SD cell , intra-cell standard deviation) was only 21 ms, further indicating relatively homogeneous behavior. By contrast, adenoviral-mediated expression of CaM D96V induced a strikingly different profile (Fig. 1C) . Here, action potentials could be enormously elongated (red), exceeding even the interstimulus interval of 2 s. For reference, the control waveform with only CaM WT present is reproduced in gray. Population data, displayed in cumulative histogram format (Fig. 1D ), reveal marked lengthening and dispersion of APD 80 values (red), with mean and standarddeviation values of 897.3 and 222.9 ms (P b 0.001). Here, SD cell increased to 156.3 ms, indicating significant variability within each cell as compared to CaM WT (P b 0.01). Both of these features furnish the cellular substrates for electrically driven arrhythmias at the tissue and organ levels [28] . Similar results were obtained for expression of CaM D130G (Figs. 1E-F, APD 80 = 915.3 ± 231.7 ms, P b 0.001; SD cell = 78.5 ms, P ≤ 0.01) and CaM F142L (Figs. 1G-H, APD 80 = 864.9 ± 320.1 ms, P b 0.001; SD cell = 179.1 ms, P b 0.01). The exemplar for CaM D130G illustrates the occurrence of alternans (Fig. 1E) , and that for CaM F142L exemplifies simple APD prolongation. All these behaviors (Figs. 1C, E, G) could be observed in the presence of any of the CaM mutants and persist at faster pacing rates ( Supplementary Fig. 2 ). Detailed parameters for action potential recordings are in Table 1 and Supplementary  Table 1 . The ability of naturally occurring LQTS CaM mutants to prolong and disperse action potentials was reminiscent of effects we and others observed previously under expression of man-made CaM mutants in the same and similar model systems [13, 30] . There, many of the action potential effects could be attributed to the suppression of a Ca 2+ / (Figs. 2D-F) . Here, CDI is strongly suppressed (f 300 = − 0.009 ± 0.008, P b 0.001), without shift in the voltage activation profile (Fig. 2E) . Similarly, coexpression of channels with CaM D130G or CaM F142L also sharply diminished CDI (Figs. 2G-I and Figs. 2J-L, f 300 = − 0.002 ± 0.011, P b 0.001 and 0.065 ± 0.005, P b 0.001, respectively). The above results were obtained with strong intracellular Ca 2+ buffering by 10 mM BAPTA, to restrict Ca 2+ elevations to those in the nanodomains of individual channels, and thereby minimize cell-to-cell variations owing to differences in current amplitudes. Importantly, however, under more physiological Ca 2 + buffering (1 mM EGTA) that allows global elevation of Ca 2+ , strong but incomplete blunting of CDI was produced by the CaM mutants ( Supplementary Fig. 4 ). This residual CDI can be attributed to signaling (Figs. 3A-C , f 300 = 0.583 ± 0.043, P N 0.01). On the other hand, CaM N98S managed only to partially diminish CDI (Figs. 3F-H , f 300 = 0.367 ± 0.023, P b 0.001). Both results in Fig. 3 were obtained under high Ca 2+ buffering conditions (10 mM BAPTA).
Under more physiological Ca 2+ buffering (1 mM EGTA), we observed a similar trend wherein CaM N54I and CaM N98S exerted at most modest diminution of CDI ( Supplementary Fig. 5 ). To assess further the more integrative consequences of these CDI profiles (Figs. 3A-C, F-H) , we investigated the effects of these CPVT CaM mutants within aGPVMs.
As might be expected, action potentials in the presence of CaM N54I
were nearly identical to those with CaM WT (Figs. 3D-E) . On the other hand, CaM N98S significantly prolonged action potentials (Figs. 3I-J, red P b 0.01) as compared to CaM WT (gray). Additionally, intra-cell standard deviation (Fig. 3J , gray bar) was also larger than CaM WT (P b 0.05), positioning CaM N98S for moderate LQTS and affiliated arrhythmias. For CaM N54I , the nearly complete lack of effect on CDI helps explain why this mutation was not associated with LQTS. Interestingly, the intermediate effects of CaM N98S on CDI and action potentials match well with reports of LQTS in an unrelated patient [35] .
Thus far, we have demonstrated the ability of the naturally occurring LQTS CaM mutants to markedly attenuate CDI of Ca V 1.2 channels heterologously expressed in HEK293 cells, to facilitate biophysical resolution. Nonetheless, we next wondered whether similar effects would be observed in native L-type Ca 2+ currents, as present in the same aGPVMs as used in Fig. 1 . Fig. 4A displays exemplar L-type currents evoked under whole-cell voltage clamp, using 10 mM BAPTA as the intracellular Ca 2+ buffer, so as to mimic the condition of Fig. 2 . Ryanodine (5 μM)
was included in the intracellular dialyzate to eliminate phasic Ca 2+ release from the sarcoplasmic reticulum, and limit CDI to that driven by Ca 2+ entry through individual L-type Ca 2+ channels [36] . We again observed strong CDI when Ca 2+ was used as the charge carrier (red)
as compared to a limited amount of voltage-dependent inactivation (VDI) seen in the Ba 2+ current (black). This additional VDI component is expected in this native setting due to a mix of endogenous beta subunits [37, 38] , compared to the pure population of β 2a subunits utilized in HEK293 cell experiments. That said, the baseline f 300 value estimating isolated CDI in control myocytes (Figs. 4A-C) was nonetheless 0.67 ± 0.04 (obtained at 20-mV step), which is quite similar to that obtained in recombinant channel expression experiments (Fig. 2C) . Likewise, population data shows a similar current-voltage relationship and U-shaped Ca 
channel CDI
We have so far demonstrated that strong overexpression of LQTSassociated CaM molecules in myocytes can produce both strongly dysfunctional electrical and Ca 2+ cycling, and potently diminished CDI.
However, in the actual related patient population, only one of six alleles encodes a mutant CaM, while the other alleles would elaborate wildtype CaM. Accordingly, we would anticipate that only a limited fraction of CaM molecules would bear the pathogenic mutation [10] . How then could the significant cardiac deficits encountered by patients be rationalized? Previous mechanistic studies of L-type channel CDI offer a potential explanation. In particular, it has been shown that for CDI to occur, channels must initially preassociate with a Ca 2+ -free CaM (apoCaM), to which subsequent Ca 2+ binding triggers CDI [15, 39] . That is, bulk CaM in the cytoplasm does not appreciably trigger CDI. Thus, if LQTSassociated mutant CaM molecules can still preassociate on par with wild-type CaM, then a sizeable fraction of channels would be bound to mutant CaM, and thus unable to undergo strong CDI (Figs. 2-3) . Thus, the overall decrease in CDI should be appreciable, reflecting the aggregate fractional presence of mutant CaM in cells. Accordingly, we utilized a well-established live-cell FRET twohybrid binding assay to determine whether mutant CaMs can still interact with Ca V 1.2, in a manner similar to wild-type CaM. Fig. 5A (top) cartoons the relevant sites of apoCaM interaction with Ca V 1.2 channels, in particular the CI region of the channel carboxy tail. Our FRET assay therefore paired the Ca V 1.2 CI region with CaM (Fig. 5A, bottom) . As baseline reference, Fig. 5B shows the canonical binding curve between (Fig. 2A) . B, Average normalized peak current-voltage relationship for same cells as in A. Compared to CaM WT (Fig. 2B) has the ability to lengthen and increase heterogeneity of action potentials (P b 0.01). Format as in Fig. 1B . Horizontal error bars in panels E and J display standard deviation of APD 80 within cells. Data for panel J from 1100 action potentials drawn from 6 myocytes.
the CI region and CaM WT , where this plot displays the acceptor-centric FRET efficiency of interaction (E A ) as a function of the relative free concentration of donor-tagged molecules D free (cerulean-CaM WT ). The curve resembles a typical binding reaction, and the D free that produces half-maximal E A yields an effective dissociation constant (K d,EFF ) of 12,000 D free units [5] . Reassuringly, all three mutant CaM molecules bind at least as well as wild-type CaM (Figs. 5B-E), demonstrating that mixed expression of mutant and wild-type CaM will result in some fraction of channels bound to mutant CaM. To test this notion quantitatively, we first devised simple means to control the expression ratio of wild-type to mutant CaM molecules (γ) (Supplementary Note 1.6). Then, we performed whole-cell electrophysiology experiments to test explicitly whether the strength of CDI in Ca V 1.2 channels would be graded by differentγ values, just as anticipated by the relative binding affinities of channels for mutant versus wild-type apoCaM (Figs. 5B-E) . Here, our approach was to strongly overexpress variable ratios of such molecules so that the contribution of endogenous CaM would be negligible. If such a scenario were to hold true, we could quantitatively predict the aggregate CDI strength (CDI) as a function of the protein expression ratio of wild-type to mutant CaM, as the Langmuir equation in Fig. 6A (Supplementary Note 1.7) . CDI WT is the full-strength CDI measured with only wild-type CaM strongly overexpressed, and K d/WT and K d/MUT are the dissociation constants for channel preassociation with wild-type and mutant apoCaM, as specified in Figs. 5B-E. Fig. 9 ). Thus, mixtures of wild-type and mutant CaM would weaken L-type channel CDI as predicted by the relative channel affinities for these two molecules in their Ca 2+ -free form. Based on the relative expression profile of each CALM during infancy [10] , heterozygous D96V mutation on CALM2 gene yieldsγ~7, predicting the substantial decrement of CDI indicated by the light rose shading in Fig. 6B , likely sufficient to appreciably prolong APDs [30, 40] . Interestingly, the corresponding prediction for a hypothetical homozygous scenario (γ~3, dark rose shading) suggests a severe reduction in CDI, potentially incompatible with life. This would perhaps predict the absence of living homozygous individuals. In all, we would argue that the electrical and calcium dysfunction affiliated with LQTS-associated CaM mutations arises as summarized in Fig. 7 . Mutant CaM elaborated by a single allele among three CALM genes would yield a mixture of wild-type and mutant CaM molecules, as specified by the expression ratioγ . Because channels must first preassociate with apoCaM to undergo subsequent CDI, this fractional expression of mutant CaM would produce graded reduction of overall CDI in myocytes, as demonstrated in Fig. 6 . This decrement of Ca 2+ feedback inhibition would elaborate abnormally long action potentials and QT intervals [13] , likely in a cell-specific manner dependent on both the precise value ofγ, and complex interactions with the configuration of other ion-channel and Ca
2+
-cycling molecules present. The latter interaction factors likely contribute to the impressive dispersion of properties documented in Fig. 1 . Given the variable propensity for action potential prolongation and calcium augmentation within different cells, arrhythmogenic behavior at the tissue and organ levels could thus result. Although other effects of mutant CaM molecules are likely to contribute to overall pathogenesis (Fig. 7 , gray pathway with arrow), this study furnishes strong evidence that a major underlying mechanism concerns the attenuation of L-type calcium channel CDI by the presence of LQTS-associated mutant CaM molecules. This outcome furnishes at least one major molecular target that merits scrutiny for potential therapeutics.
Discussion
Our experiments demonstrate that CaM bearing LQTS mutations induce the cellular substrates that would favor a LQTS phenotype. Acute introduction of LQTS mutant CaMs into aGPVMs leads to: (1) electrical disturbances including prolonged APD and electrical alternans, as well as (2) Ca 2+ cycling disturbances, such as increased Ca 2+ transients and SR Ca 2+ load. Importantly, such alterations manifested in a highly dispersed fashion across and within cells, thus furnishing a critical ingredient for arrhythmogenesis at the tissue and organ levels [28] . The present study also clearly indicates that a key contributor to these effects involves the disruption of L-type channel CDI by LQTS CaM mutants. Such CDI attenuation would elaborate increased Ca 2+ current during phases 2 and 3 of the action potentials, thus prolonging APD and increasing SR Ca 2+ load. Finally, we have established one scenario by which a small fraction of CaM mutants would suffice to create an appreciable prolongation of action potentials. Preassociation of apoCaM to the Ca V 1.2 channels plays a critical role, enabling a fraction of channels to be occupied by the CaM mutants with resulting failure to undergo CDI. Interestingly, CaM mutants commonly affiliated with CPVT exhibited negligible or weaker effects on action potential duration and L-type channel CDI. The complete lack of effect of CaM N54I on CDI and action potential duration is well explained by its near wild-type Ca 2+ binding affinity [41] , and these molecular and cellular outcomes fit nicely with the lack of appreciable QT prolongation in corresponding probands [9] . This CPVT-associated mutant could nonetheless interact with other targets like RyR2 calcium release channels to potentially contribute to pathogenesis [41] . On the other hand, the CPVT CaM mutant N98S is capable of producing either CPVT [9, 41] or LQTS in patients [35] . This dual effect may well arise from the overlapping effects of these mutations on multiple CaM targets in the heart. Indeed, CaM N98S turned out to both reduce L-type channel CDI and moderately prolong cardiac action potentials (Fig. 3) . The intermediate effects of this CaM mutant thus rationalize how LQTS or CPVT may become the more prominent clinical phenotype, perhaps as a function of differing expression levels among patients.
In addition to L-type (Ca V 1.2) channels, other molecular targets of CaM remain as potential contributors to LQTS pathogenesis. Focusing in particular on targets that preassociate with Ca 2+ -free CaM, voltagegated Na channels [42] (Na V 1.5) and slow delayed rectifier K channels [43] (I Ks ) loom among likely targets. In Na V 1.5 channels, Ca 2+ /CaM is proposed to both facilitate initial opening and stabilize the inactivated state [42] . However, a recent study reports that LQTS CaM mutants lacked significant effects on most splice variants of Na V 1.5 channels, though the CaM D130G mutant appeared to moderately enhance persistent current in one fetal splice variant [44] . For I Ks , Ca 2+ -free CaM may help traffic channels to plasmalemma [45] , and Ca 2+ /CaM is believed to facilitate opening. In fact, mutations in I Ks that disrupt CaM binding result in decreased K current, thus causing LQTS [43, 46] . More broadly, because CaM regulates many other Ca 2+ channel subtypes, including those predominate in neurons and immune cells, disruption of CDI could lead to a multi-system disorder similar to Timothy syndrome [47] [48] [49] . It may well be that extra-cardiac effects are also present in patients possessing LQTS CaM mutants, but that these effects were not recognized in the face of immediately life-threatening cardiac-related sequelae. For other CaM-modulated signaling molecules that do not preassociate with Ca 2+ -free CaM, the present study would suggest that a limited fraction of LQTS CaM mutants would matter little. Only when the fraction of CaM mutants approaches unity would this class of targets be predicted to exhibit altered function. Key members of this class of CaM targets in cardiac myocytes would include Ca 2+ / CaM-dependent kinase II (CaMKII) and calcineurin (CN). CaMKII has been argued to influence the electrical properties of cardiomyocytes by phosphorylation of ryanodine receptors, phospholamban, SERCA, and L-type Ca 2+ channels, all of which could alter electrical and Ca 2+ function [50] . By contrast, the Ca 2+ /CaM-activated phosphatase CN dephosphorylates numerous targets including the transcription factor NFAT, implicated in regulating expression levels of numerous ion channels in heart [51] . Nonetheless, if our insights are correct regarding the necessary role of target preassociation with apoCaM to amplify the effects of a limited fraction of CaM mutants, molecules like CaMKII and CN may play little role in the LQTS phenotype at hand. Even before testing for a role of the additional target molecules alluded to above, potential targeted therapeutic strategies in patients expressing LQTS CaM mutants are suggested by our finding that LTCC dysfunction likely contributes in this particular setting. In addition to beta-adrenergic blockade, as per the general standard of care for LQTS patients, immediate benefits may arise by seeking appropriate modulators of LTCCs such as roscovitine, which has demonstrated beneficial effects within certain in vitro models of LTCC-related LQTS [52] . Additionally, a recent study implicates a non-linear threshold effect between the extent of CDI diminution in LTCCs and onset of outright arrhythmias [53] , rather than a continuously graded interrelation. Accordingly, only a few-fold decrease in the fraction of CaM mutants (γ ) may yield marked improvement of electrical stability and decrease in the incidence of cardiac arrest. The limited alteration ofγ potentially required to bring about these benefits may considerably improve the feasibility of devising novel therapies towards this end.
Although the prevalence of diseases caused by de novo CaM mutations is limited, investigating their pathogenesis may offer revealing opportunities to expand our basic knowledge of LQTS-related arrhythmogenesis. Moreover, additional discoveries of CaM mutations will help expand our database of related genotype-phenotype correlations, lending further resources for understanding. Indeed, following the first discoveries of CaM mutations, three more recent preliminary studies [35, 54, 55] have uncovered further CaM-affiliated arrhythmias. These include the following, listed according to gene and syndrome: D134H (CALM2; LQTS), N98S (CALM2; LQTS), D132F (CALM2; LQTS and CPVT), N54I (CALM1; LQTS and/or sudden unexplained death in the young (SUDY)), A103V (CALM3; CPVT and/or SUDY), F90L (CALM1; ventricular fibrillation). These exciting discoveries suggest that a small yet substantial population of patients with CaM mutations is emerging, thus necessitating the inclusion of CALM genes in genetic test panels for LQTS and CPVT, and providing added motivation for the discovery of new therapies. In this light, it may be warranted to dub this expanding group of CaM-related disorders as calmodulinopathies. To confirm our findings that LQTS CaM mutants can recapitulate the long-QT phenotypes at more than a single pacing rate, we also recorded action potential waveforms at faster pacing frequencies.
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Calibrating the expression ratio of wild-type to mutant CaM
Before being able to accurately test the graded response of CDI at different expression ratios of wild-type to mutant CaM, we first needed to devise a method to control and validate the protein expression ratio relative to a transfected cDNA ratio. Through a simplistic yet powerful imaging method, we were able to determine a scaling factor m that relates the protein expression ratio (γ ) to cDNA transfection ratio (γ ) as
First, we assessed the relative brightness of venus-and cerulean-tagged CaM WT (V-CaM WT and C-CaM WT , in Supplementary Figure 6A ). An equimolar ratio of cDNAs encoding these moities was transfected into HEK293 cells, and cell-by-cell epifluorescence imaging undertaken 1-2 days thereafter.
Under these conditions, cells should on average express equal amounts of V-CaM WT and C-CaM WT . C, Plotting γ as a function of γ yields a linear relation with a slope equal to the final conversion factor m.
For the remaining two LQTS mutants, we confirmed that these mutations exhibit a similar m value, as follows. Holding γ = 1 (equimolar cDNA ratio of wild-type to mutant CaM) fixed for CaM D130G and CaM F142L , the resulting γ data points (colored symbols, Supplementary Figure 7) nicely superimpose on the γ versus γ relation for CaM D96V (reproduced as black symbols and fit, from Supplementary Figure   6 ). Thus, we could use the same value of m throughout (~1).
Derivation of Langmuir CaM Ratio Equation
With careful calibrations of CaM protein expression in hand, we could quantify the graded CDI effects of the mutant CaMs. Since all three LQTS mutations are in the C-lobe of CaM, we continued to utilize high intracellular buffering (10 mM BAPTA) such that we need only consider C-lobe CaM regulation [1, 2] in our derivations. In addition, we have shown that the mutant apoCaMs can bind to the channels at least as well as the wild-type counterpart ( Figures 5B-E) . Therefore, at baseline, each channel will be in one of the first three configurations depicted in Supplementary Figure 8 : empty (state 1); occupied by a wild-type apoCaM (state 2), or occupied by a mutant apoCaM (state 3). Furthermore, to minimize the effect of endogenous CaM, we strongly expressed a mixture of wild-type and mutant CaM molecules.
Under this condition, essentially all channels will be occupied by apoCaM at rest, restricting occupancy to either state 2 or 3 at baseline. Upon a rise in intracellular Ca 2+ , CaM WT will bind Ca 2+ and induce conformational changes which result in CDI (state 4). All LQTS CaM mutants, on the other hand, feature 
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